From March 18th to 22nd, 2019, a group of 3 people from the IKSA expert group visited Minhai to evaluate the operation of the quality system of Minhai. Nie Xiaoqi and other relevant department leaders expressed a warm welcome to the visit of IKSA experts.
Zhang Qian, the Ministry of International Cooperation of Minhai, introduced the basic situation of the company to the IKSA expert group, and then took Hib combined vaccine as an example. Department), the IKSA expert group analyzed the gap between our company's quality system and WHO requirements.
After 5 days of intensive inspection, the IKSA expert team gave a real, detailed and comprehensive analysis and summary report on the operation of our company ’s quality system, which provided good suggestions for our company to pass the WHO pre-certification in the future, but also for our company The quality assurance system puts forward higher and stricter requirements. Company leaders said that they must enhance our company's quality awareness and quality system in accordance with the requirements of WHO, and guarantee product quality comprehensively and systematically.
